ZLD
Click for more information
0.00% 63.0¢ zelira therapeutics limited

Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial, page-20

  1. Mcdunk
    2,567 Posts.
    lightbulb Created with Sketch. 482
    clock Created with Sketch.
    10/06/21
    17:40
    Post #: 53775402
    At Zelira we are continuing to bring new light to the medicinal cannabis industry through research and the development of new products. Andreas Lundberg from rogermontgomery.com takes a look at Zelira's bright future in the burgeoning medicinal cannabis industry here: https://rogermontgomery.com/building-an-export-industry-for-cannabis-medicines
    https://rogermontgomery.com/building-an-export-industry-for-cannabis-medicines//
    ZLD Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
63.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.148M
Open High Low Value Volume
63.0¢ 63.0¢ 63.0¢ $636 1.01K

Buyers (Bids)

No. Vol. Price($)
1 1190 63.0¢
 

Sellers (Offers)

Price($) Vol. No.
73.0¢ 4489 3
View Market Depth
Last trade - 13.56pm 26/07/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.